
Author: Truehope
Pharmaceutical companies buying out supplement companies
Last month, the media quietly announced Bayer’s desire to purchase supplement maker Schiff Nutritional for $1.2 billion. Just last week, British drug company Reckitt announced it wanted in on the action, upping the offer for Schiff to $1.4 billion.
No matter who ends up buying it, the sale of Schiff Nutritional would total over a billion dollars, and would put a pharmaceutical company in charge of the production of nutritional supplements.